Company Overview and News

 
Is Legal Sports Betting Boon or Bane for Casino Gaming ETF?

2018-05-15 zacks
Things are looking up for Casino stocks and ETFs. VanEck Vectors Gaming ETF (BJK - Free Report) has gained about 7.2% so far this year (as of May 14, 2018), beating the S&P 500 (up 1.3%) on a volley of favorable happenings in the space. On Monday, casino stocks jumped on the news of legalization of sports betting in several U.S. states. The casino ETF BJK in fact added 2.2% on May 14 (read: Basket March Madness Gains With These ETFs).

3
Stocks To Watch: A Fed Head Talks Crypto

2018-05-12 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.

 
UPDATE 1-Macau's Galaxy posts 36 pct rise in Q1 EBITDA, eyes overseas expansion push

2018-05-03 reuters
HONG KONG, May 3 (Reuters) - Macau casino operator Galaxy Entertainment Group posted a 36 percent rise in its first-quarter EBITDA due to resurgent demand from gamblers in the world’s biggest casino hub.

 
Macau's Galaxy Entertainment posts 36 pct rise in Q1 EBITDA

2018-05-03 reuters
HONG KONG, May 3 (Reuters) - Macau casino operator Galaxy Entertainment Group posted a 36 percent rise in its first-quarter EBITDA due to resurgent demand from gamblers in the world’s biggest casino hub.

 
Macau casino SJM posts 26 pct rise in Q1 profit

2018-05-02 reuters
HONG KONG, May 2 (Reuters) - Macau casino SJM Holdings posted a 25.8 percent rise in its first-quarter net profit on Wednesday on strong gambling demand in the only place in China where casinos are legal.

2
Stocks To Watch: Apple, FOMC And China On Tap

2018-04-28 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.

 
Las Vegas Sands (LVS) Q1 2018 Results - Earnings Call Transcript

2018-04-26 seekingalpha
Good afternoon my name is Litvaya and I'll be your conference operator today. At this time I'd like to welcome everyone to the Las Vegas Sands First Quarter 2018 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

 
What to look for as Q1 earnings hit around the globe

2018-04-18 themalaymailonline
Johnson & Johnson says as a result of tax reform, it plans to increase spending on research and capital investment by 15 per cent over the next four years. — Reuters picNEW YORK, April 18 — Trade, taxes and China are the main themes to watch for heading into first-quarter earnings, along with a spate of potential deals.

 
What to Look for as First-Quarter Earnings Hit Around the Globe - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Investors propel shares of Hainan linked companies on plans to start horse racing, sports lotteries

2018-04-16 scmp
Shares of most Hainan-based companies jumped by their 10 per cent daily limit on Monday after Beijing said it would allow the southernmost province to develop horse racing and sports lotteries as part of plans to turn the island into China’s biggest pilot free-trade port.

 
Wynn's Pain Is Rivals' Gain With Macau Facing a Shakeup - Bloomberg

2018-03-23 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Steve Wynn sells stake in company he founded, Macau casino Galaxy buys in

2018-03-23 themalaymailonline
Steve Wynn, Chairman and CEO of Wynn Resorts, speaks during the Milken Institute Global Conference in Beverly Hills, California May 3, 2017. — Reuters picLAS VEGAS, March 23 — Steve Wynn, the former chief executive of Wynn Resorts Ltd, is selling all his remaining eight million shares in the firm in a dramatic exit of the casino and hotel company he founded over 16 years ago.

 
Steve Wynn sells stake in company he founded, Macau casino Galaxy buys in

2018-03-23 channelnewsasia
Wynn Resorts Ltd said on Thursday that former Chief Executive Steve Wynn no longer holds a stake in the company after he agreed to sell all his remaining 8 million shares in privately negotiated transactions.

 
Macau move to curtail foreign judges sparks concerns over China's growing control

2018-03-08 channelnewsasia
MACAU: Macau has finished drafting a proposed new law barring foreign judges from hearing national security and defence cases, an unprecedented move that has heightened concerns over Beijing's grip over the gambling hub.

 
Macau casino operator Galaxy Entertainment’s profit surges 67pc as gaming market recovers

2018-02-28 scmp
Galaxy Entertainment Group, one of the six major casino operators in Macau, reported better-than-expected earnings for 2017, thanks to rapid growth in its VIP and mass segments amid a gaming market recovery in the city.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...